Table 5.
Effects of HIIT spinning exercise intervention on biochemical variables and hormones.
| Control (1) | Dysmen (2) | DysmenHIIT (3) | ||||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| AST (U/L) | 16.1 ± 6.5 | 13.2 ± 3.0 | 15.3 ± 2.3 | 14.3 ± 3.8 | 15.0 ± 2.2 | 13.8 ± 2.3 |
| ALT (U/L) | 09.5 ± 3.7 | 09.4 ± 3.4 | 09.0 ± 2.3 | 09.2 ± 4.6 | 07.1 ± 2.2 | 07.4 ± 2.8 |
| BUN (mg/dL) | 11.5 ± 3.6 | 12.3 ± 3.8 | 11.4 ± 2.1 | 12.3 ± 3.1 | 13.7 ± 3.6 | 13.4 ± 3.6 |
| CREA (mg/dL) | 0.66 ± 1.14 | 0.63 ± 0.08 | 0.66 ± 0.64 | 0.66 ± 0.05 | 0.72 ± 0.08 | 0.70 ± 0.09 |
| TG (mg/dL) | 64.7 ± 23 | 59.2 ± 12 | 69.7 ± 15 | 70.4 ± 19 | 67.1 ± 26 | 67.3 ± 21 |
| CHOL (mg/dL) | 161. ± 37 | 154. ± 29 | 158. ± 22 | 155. ± 26 | 160. ± 20 | 158. ± 19 |
| LDH (U/L) | 112. ± 18 | 103. ± 12 | 113. ± 15 | 108. ± 18 | 125. ± 20 | 116. ± 18 * |
| CPK (U/L) | 101. ± 86 | 083. ± 69 | 103. ± 48 | 071. ± 49 | 109. ± 58 | 104. ± 51 |
| HsCRP (mg/dL) | 0.031 ± 0.02 2,3 | 0.037 ± 0.02 2 | 0.136 ± 0.02 1 | 0.139 ± 0.11 1,3 | 0.134 ± 0.06 1 | 0.043 ± 0.03 2,* |
| Estradiol (pg/mL) | 188 ± 51 2,3 | 177 ± 41 2 | 233 ± 35 1 | 228 ± 40 1,3 | 221 ± 34 1 | 174 ± 37 2,* |
| FSH (mIU/mL) | 03.8 ± 1.7 | 4.0 ± 2.5 | 04.1 ± 2.3 | 4.5 ± 2.5 | 04.2 ± 2.4 | 3.5 ± 1.7 |
| LH (mIU/mL) | 08.1 ± 5.2 | 5.7 ± 3.1 | 07.4 ± 6.3 | 6.8 ± 5.0 | 06.1 ± 3.9 | 6.1 ± 4.2 |
| PRL (ng/mL) | 24.3 ± 9.0 3 | 25.9 ± 8.3 2 | 32.8 ± 9.0 | 33.7 ± 7.8 1 | 35.7 ± 15 1 | 28.0 ± 12 * |
| Progesterone (ng/mL) | 11.7 ± 4.6 2,3 | 11.2 ± 4.1 2 | 05.8 ± 3.7 1 | 06.0 ± 5.3 1,3 | 05.4 ± 4.2 1 | 9.7 ± 2.2 2,* |
| Cortisol (μg/dL) | 9.6 ± 3.3 3 | 11.6 ± 2.8 2 | 7.9 ± 2.6 | 8.7 ± 3.1 1,3 | 6.7 ± 2.3 1 | 11.6 ± 3.6 2,* |
Control and Dysmenorrhea groups were defined according to the definitions of inclusion criteria from the VAS scores of the Short Form McGill Pain Questionnaire in the current study. Superscripts numbers (1, 2, and 3) indicate significant differences (P < 0.05) between the groups
‘*’ indicates significant differences between pre- or post-testing.